A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression-Reference-Cited by-同舟云学术

A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression

Published:2015-09 Issue:3 Volume:17 Page:341-352
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Kikushige Yoshikane,Miyamoto Toshihiro,Yuda Junichiro,Jabbarzadeh-Tabrizi Siamak,Shima Takahiro,Takayanagi Shin-ichiro,Niiro Hiroaki,Yurino Ayano,Miyawaki Kohta,Takenaka Katsuto,Iwasaki Hiromi,Akashi Koichi

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference57 articles.

1. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells;Akashi;J. Clin. Invest.,1991

2. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells;Anderson;Science,2007

3. Adaptive linear step-up procedures that control the false discovery rate;Benjamini;Biometrika,2006

4. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway;Birkenkamp;Leukemia,2004

5. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell;Bonnet;Nat. Med.,1997

Cited by 225 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OMIP‐106: A 30‐color panel for analysis of check‐point inhibitory networks in the bone marrow of acute myeloid leukemia patients;Cytometry Part A;2024-08-27

2. Role of TIM-3 in ovarian cancer: the forsaken cop or a new noble;Frontiers in Immunology;2024-08-13

3. TOX2 nuclear-cytosol translocation is linked to leukemogenesis of acute T-cell leukemia by repressing TIM3 transcription;Cell Death & Differentiation;2024-07-30

4. The Immune Resistance Signature of Acute Myeloid Leukemia and Current Immunotherapy Strategies;Cancers;2024-07-23

5. Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti–TIM-3 therapy in mice;Journal of Clinical Investigation;2024-06-25